menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Pharma and Biotech Industries Pursue Treatments for Cardiac Inflammation

close
Pharma and Biotech Industries Pursue Treatments for Cardiac Inflammation
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    A treatment for atherosclerosis and the chronic inflammation in arterial blood vessels could be entering critical clinical trial stages that may result in a novel new treatment. Dr. Lawrence Cohen, president and chief executive officer of VIA Pharmaceuticals lays out for host Chicago Tribune's Bruce Japsen the landscape of large pharmaceutical companies as well as smaller biotech companies that are making progress in bringing these treatments through the clinical trial process. They are closer than you might think.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    A treatment for atherosclerosis and the chronic inflammation in arterial blood vessels could be entering critical clinical trial stages that may result in a novel new treatment. Dr. Lawrence Cohen, president and chief executive officer of VIA Pharmaceuticals lays out for host Chicago Tribune's Bruce Japsen the landscape of large pharmaceutical companies as well as smaller biotech companies that are making progress in bringing these treatments through the clinical trial process. They are closer than you might think.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 6/5/20